Mersana Therapeutics, Inc.
MRSN
$0.3876
-$0.0124-3.10%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -14.12M | -11.50M | -24.27M | -19.31M | -19.54M |
| Total Depreciation and Amortization | 400.00K | 402.00K | 403.00K | 423.00K | 447.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 3.65M | 3.96M | 3.99M | 4.36M | 4.64M |
| Change in Net Operating Assets | -9.19M | -1.44M | -1.98M | -18.13M | -17.50M |
| Cash from Operations | -19.25M | -8.58M | -21.86M | -32.66M | -31.96M |
| Capital Expenditure | 0.00 | 0.00 | 0.00 | -132.00K | -386.00K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 50.00M | 28.47M | 5.51M | -72.42M | 20.53M |
| Cash from Investing | 50.00M | 28.47M | 5.51M | -72.55M | 20.15M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -2.10M | -23.00K | -47.00K | -65.00K | -66.00K |
| Issuance of Common Stock | 228.00K | 0.00 | 200.00K | 5.89M | 158.00K |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | 0.00 |
| Cash from Financing | -1.87M | -23.00K | 153.00K | 5.83M | 92.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 28.88M | 19.87M | -16.19M | -99.38M | -11.72M |